Cardio Diagnostics Holdings, Inc. (CDIOW) stock
CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $4.94MP/E –Yield –
Cardio Diagnostics operating margin
Operating margin is operating income as a percentage of revenue.
Cardio Diagnostics's operating margin for the twelve months ending Dec 31, 2025 was -43737.5%. For fiscal 2025 it was -43737.5%, against -23977.9% the year before. The highest annual figure on record is -23977.9% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -43737.5% | −19759.6 |
| FY2024 | Dec 31, 2024 | -23977.9% | +18462.6 |
| FY2023 | Dec 31, 2023 | -42440.4% | +436343.9 |
| FY2022 | Dec 31, 2022 | -478784.3% | −409922.2 |
| FY2021 | Dec 31, 2021 | -68862.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -27950.5% | +5657.7 |
| Q1 FY2026 | Mar 31, 2026 | -66598.4% | −45185.5 |
| Q4 FY2025 | Dec 31, 2025 | -41159.5% | −24864.0 |
| Q1 FY2025 | Mar 31, 2025 | -173463.8% | −147358.6 |
| Q4 FY2024 | Dec 31, 2024 | -33608.2% | −4568.7 |
| Q3 FY2024 | Sep 30, 2024 | -21412.9% | −7014.2 |
| Q2 FY2024 | Jun 30, 2024 | -16295.6% | +131712.6 |
| Q1 FY2024 | Mar 31, 2024 | -26105.3% | – |
| Q4 FY2023 | Dec 31, 2023 | -29039.5% | – |
| Q3 FY2023 | Sep 30, 2023 | -14398.7% | – |
| Q2 FY2023 | Jun 30, 2023 | -148008.2% | – |